Skip to main content
. 2012 Apr 24;16(2):183–198. doi: 10.1016/j.cld.2012.03.006

Fig. 1.

Fig. 1

(A–B) Algorithm for the evaluation of abnormal liver enzymes. A1AT, α1-antitrypsin; Ab, antibody; ALT, alanine aminotransferase; AMA, antimitochondrial antibody; ANA, antinuclear antibody; CMV, cytomegalovirus; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; GGT, γ-glutamyltransferase; HAV, hepatitis A virus; HBsAg, hepatitis B surface antigen; HBc, hepatitis B core; HCV, hepatitis C virus; IgM, immunoglobulin M; MRCP, magnetic resonance cholangiopancreatography; NAFLD, nonalcoholic fatty liver disease; pANCA, perinuclear antineutrophil cytoplasmic antibodies; SMA, anti-smooth muscle antibodies; SPEP, serum protein electrophoresis; US, ultrasonography.